yes upward slant and the tide is turning even my .27s are looking good the vix is high here and the stock can move up on a whim unexpectedly upwards however with fda tickets new possibilities and probabilities higher if postive blue skies as bidding wars ensue for the 7.1 billion market next year in the molecular diagnosis where gbsn is considered a player
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.